172 related articles for article (PubMed ID: 1575219)
1. Bromodeoxyuridine and deoxyribonucleic acid bivariate analysis in human renal cell carcinoma. Does flow cytometric determination predict malignant potential or prognosis of patients with renal cell carcinoma?
Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S38-47. PubMed ID: 1575219
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric measurements of deoxyribonucleic acid ploidy and proliferative activity for evaluating malignant potential of human bladder cancers.
Miyakawa A; Tachibana M; Tazaki H
Cancer Detect Prev; 1995; 19(2):165-72. PubMed ID: 7750104
[TBL] [Abstract][Full Text] [Related]
3. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
Meyer JS; Gersell DJ; Yim S
Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
[TBL] [Abstract][Full Text] [Related]
4. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
Ljungberg B
Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
[TBL] [Abstract][Full Text] [Related]
5. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
Tachibana M; Miyakawa A; Nakamura K; Baba S; Murai M; Tazaki H
J Urol; 1996 Jul; 156(1):63-9. PubMed ID: 8648839
[TBL] [Abstract][Full Text] [Related]
6. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
[TBL] [Abstract][Full Text] [Related]
8. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
9. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Hass HG; Schmidt A; Nehls O; Kaiser S
Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
[TBL] [Abstract][Full Text] [Related]
10. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
Wu YF; Xu HM; Chen JQ
Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in patients with renal cell carcinoma.
Yokogi H
Cancer; 1996 Aug; 78(4):819-26. PubMed ID: 8756377
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of flow cytometric, static cytometry and tumor cytogenetic investigation results human renal cell carcinomas].
Krech RH; Baretton G; Fonatsch C; Diebold J; Früchtnicht W; Löhrs U
Verh Dtsch Ges Pathol; 1990; 74():228-32. PubMed ID: 1708590
[TBL] [Abstract][Full Text] [Related]
13. DNA cytophotometry in renal cell carcinoma: a significant prognostic factor?
Feil G; Mittermüller B; Bichler KH; Wunderer A; Wechsel HW; Nelde HJ; St Krause F
Anticancer Res; 1999; 19(2C):1483-6. PubMed ID: 10365128
[TBL] [Abstract][Full Text] [Related]
14. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2 protein and DNA ploidy in renal cell carcinoma: do they affect patient prognosis?
Skolarikos A; Alivizatos G; Bamias A; Mitropoulos D; Ferakis N; Deliveliotis C; Dimopoulos MA
Int J Urol; 2005 Jun; 12(6):563-9. PubMed ID: 15985079
[TBL] [Abstract][Full Text] [Related]
16. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma.
Eskelinen M; Lipponen P; Nordling S
Anticancer Res; 1995; 15(5B):2279-83. PubMed ID: 8572637
[TBL] [Abstract][Full Text] [Related]
17. [Malignancy in gastric carcinoma, with special reference to the DNA ploidy and proliferative activity].
Yonemura Y; Sugiyama K; Kamata T; Fujimura T; Yamaguchi A; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1988 Aug; 89(8):1175-80. PubMed ID: 3054478
[TBL] [Abstract][Full Text] [Related]
18. [Flow cytometric analysis of renal cell carcinoma].
Lü GH
Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):27-9. PubMed ID: 2364867
[TBL] [Abstract][Full Text] [Related]
19. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.
Coleman RL; Schink JC; Miller DS; Bauer KD; August CZ; Rademaker AW; Lurain JR
Gynecol Oncol; 1993 Jul; 50(1):20-4. PubMed ID: 8349159
[TBL] [Abstract][Full Text] [Related]
20. [Cell kinetic analysis and treatment planning in epidermoid tumors of the head and neck].
Margarino G; Scala M; Schenone G; Mereu P; Corvo R; Sanguineti G; Giaretti W; Geido E; Orecchia R; Meszaros P
Acta Otorhinolaryngol Ital; 1992; 12(5):421-33. PubMed ID: 1303006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
